Hopp til hovedinnhold

Hypertriglyseridemi

Hypertriglyseridemi er en tilstand med forhøyede triglyseridverdier i blodet og regnes som en risikofaktor for hjerte- og karsykdom. Triglyserider utgjør en viktig del av fettstoffene (lipidene) som sirkulerer i blodet.

Sist revidert:
QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/hormoner-og-naring/kolesterol-og-fett/hypertriglyseridemi/ 

Hva er hypertriglyseridemi?

Årsak

Symptomer

Diagnosen

Behandling

Prognose

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Hypertriglyseridemi. Referanselisten for dette dokumentet vises nedenfor.

  1. Brunzell JD. Hypertriglyceridemia. N Engl J Med 2007; 357: 1009-17. PubMed 
  2. Kushner PA, Cobble ME. Hypertriglyceridemia: the importance of identifying patients at risk. Postgrad Med. 2016 Nov;128(8):848-58. PubMed 
  3. Leaf DA. Hypertriglyceridaemia. BMJ Best Practice, last updated May 2018. bestpractice.bmj.com 
  4. Sweeney MET. Hypertriglyceridemia. Medscape. Last updated May 30, 2014. http://emedicine.medscape.com/article/126568-overview.
  5. Tontstad S. Ny forståelse av hypertriglyseridemi og hjerte- og karsykdom. Indremedisineren, 26.10.2018. indremedisineren.no 
  6. Beigneux AP, Miyashita K, Ploug M, et al. Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia. N Engl J Med 2017: 376:1647-58. doi: 10.1056/NEJMoa1611930 DOI 
  7. Oh RC, Trivette ET, Westerfield KL. Management of Hypertriglyceridemia: Common Questions and Answers. Am Fam Physician. 2020;102(6):347-354. PubMed 
  8. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2011; 123: 2292-333. Circulation 
  9. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014 ;384(9943):626-35. doi: 10.1016/S0140-6736(14)61177-6 DOI 
  10. Di Angelantonio E, Sarwar N, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000. PMID: 19903920 PubMed 
  11. Zambon A, Brown BG, Deeb SS, Brunzell JD. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease. J Intern Med 2006; 259: 473-80. PubMed 
  12. Khera AV, Won H-H, Peloso GM, et al. Association of rare and common variation in the lipoprotein lipase gene with coronary artery disease. JAMA 2017; 317: 937-46. doi: 10.1001/jama.2017.0972 DOI 
  13. Mach F, Baigent C, Catapano CL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J 2020; 41: 111-188. pmid:31591002 PubMed 
  14. Bhatt DL, Steg PG, Miller M, et al; REDUCE-IT Investigators. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med 2019; 380: 11-22. pmid:30415628 PubMed 
  15. Stroes ESG, Susekov AV, de Bruin TWA, et al. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial. J Clin Lipidol 2018; 12: 321-330. pmid:29289538 PubMed 
  16. Skulas-Ray AC, Wilson PWF, Harris WS, et al. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia A Science Advisory From the American Heart Association. Circulation 2019. doi:10.1161/CIR.0000000000000709 DOI 
  17. Karlson BW, Palmer MK, Nicholls SJ et al. A Voyager meta-analysis of the impact of statin therapy on low-density lipoprotein cholesterol and triglyseride levels in patients with hypertriglyceridemia. Am J Cardiol 2016; 117: 1444-8. PubMed 
  18. Madsen CM, Varbo A, Nordestgaard BG. Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study. Eur Heart J. 2018;39(7):610-619. PubMed 
  19. Freiberg JJ, Tybjærg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 2008; 300: 2142-52. Journal of the American Medical Association 
  20. Mozafarrian D, Maki KC, Bays HE, et al. Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia A Randomized Clinical Trial. JAMA Netw Open 2022. doi:10.1001/jamanetworkopen.2021.41898 DOI 
  21. Stone NJ, Bilek S, Rosenbaum S. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Am J Cardiol 2005; 96: 53-9. PubMed 
  22. Aung T, Halsey J, Kromhout D, et al. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. JAMA Cardiol. 2018;3(3):225-234. PubMed